Type 1 Diabetes Clinical Trials in Minneapolis, Minnesota

3 studies are recruiting for type 1 diabetes in Minneapolis, Minnesota right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes

    This multi-center randomized controlled trial will assess the safety and efficacy of ATG followed by either adalimumab or verapamil in preserving insulin secretion 2 years from randomization in persons aged 9 to <21 with recent-onset stage 3 T1D.

    Stage
    Phase 1
    Ages
    9 to 20
    Site
    University of Minnesota, Minneapolis, Minnesota
    Locations
    11 in total
    Run by
    City of Hope Medical Center

    See if you can join NCT07061574 on ClinicalTrials.gov

  2. Safety and Efficacy of Adjunct Therapies in Adults With Type 1 Diabetes: Multicenter, Registry Study

    This will be a multicenter registry-based study to evaluate safety and efficacy of GLP-1RA and SGLTi therapies in adjunct to insulin in adults with type 1 diabetes (T1D) over 1 year. This study will enroll participants who have been prescribed adjunct therapy as part of usual care.

    Stage
    Not phased
    Ages
    18 and older
    Site
    HealthPartners, International Diabetes Center, Minneapolis, Minnesota
    Locations
    17 in total
    Run by
    Indiana University

    See if you can join NCT07676565 on ClinicalTrials.gov

  3. CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)

    This study is a Phase 1b/2a First-in-Human (FIH) clinical trial to assess the safety, tolerability, pharmacodynamics (PD), and efficacy of multiple ascending doses of CNP-103. The approximately 393-days study consists of a Screening Period (28 days), Treatment Period (90 days), and Post-Dose Evalua…

    Stage
    Phase 1
    Ages
    12 to 35
    Site
    University of Minnesota, Minneapolis, Minnesota
    Locations
    45 in total
    Run by
    COUR Pharmaceutical Development Company, Inc.

    See if you can join NCT06783309 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.